Your browser doesn't support javascript.
loading
Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy.
Banse, H E; Whitehead, A E; McFarlane, D; Chelikani, P K.
Affiliation
  • Banse HE; Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA. Electronic address: hbanse1@lsu.edu.
  • Whitehead AE; Department of Veterinary and Clinical Diagnostic Sciences, University of Calgary, Calgary, AB, T2N 4Z6, Canada.
  • McFarlane D; Department of Physiological Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, 74078, USA.
  • Chelikani PK; School of Veterinary Medicine, Texas Tech University, Amarillo, TX 79106, USA.
Domest Anim Endocrinol ; 76: 106620, 2021 07.
Article in En | MEDLINE | ID: mdl-33740552
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Diseases / Pituitary Gland, Intermediate / Horse Diseases Limits: Animals Language: En Journal: Domest Anim Endocrinol Journal subject: ENDOCRINOLOGIA / MEDICINA VETERINARIA Year: 2021 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Diseases / Pituitary Gland, Intermediate / Horse Diseases Limits: Animals Language: En Journal: Domest Anim Endocrinol Journal subject: ENDOCRINOLOGIA / MEDICINA VETERINARIA Year: 2021 Document type: Article Country of publication: Estados Unidos